Covaxin gets emergency approval for kids aged 2-18 years by Subject Expert Committee
New Delhi: In a major gain, India’s indigenous COVID vaccine — Covaxin — has been approved for children aged 2-18 years by the Subject Expert Committee (SEC) this noon.






